Healthcare - Biotechnology - NASDAQ - US
$ 2.75
-3.85 %
$ 211 M
Market Cap
-6.25
P/E
Price Target
Average
161.82%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
28.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Trevi Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TRVI of $7.2 , with forecasts ranging from a low of $6 to a high of $12 .
TRVI Lowest Price Target
Wall Street Target
6 USD
118.18%
TRVI Average Price Target
Wall Street Target
7.2 USD
161.82%
TRVI Highest Price Target
Wall Street Target
12 USD
336.36%
REVENUE FORECAST
Revenue Forecast Chart TRVI
EBIT FORECAST
EBIT Forecast Chart TRVI
NET INCOME FORECAST
Net Income Chart TRVI